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We investigated the prostatic anterior fat pad (PAFP) for the presence of lymph nodes and lymph node
metastases after excision during radical prostatectomy for the treatment of prostate cancer. From
November 2013 to May 2017, 215 patients underwent radical prostatectomy for localized prostate cancer at
our institution. PAFP was removed and sent for pathological analysis routinely to evaluate the presence of
lymph nodes and lymph node metastases. Of the 215 patients, 20 (9.3%) had lymph nodes in the PAFP.
Among the 20 patients with lymph nodes in the PAFP, 2 patients (10.0% ; 0.9% of all patients) were positive
for metastatic prostate cancer. These patients did not have positive nodes elsewhere among the pelvic
lymph nodes. There was no significant difference in the clinicopathological features between the patients
with lymph nodes in the PAFP and those with no lymph nodes in the PAFP. The present findings are
similar to those in the Western population. Considering the very low rate of lymph node metastasis in
PAFP, it is necessary to discuss which patients should be selected for pathological analysis of PAFP.
(Hinyokika Kiyo 64 : 359-363, 2018 DOI : 10.14989/ActaUrolJap_64_9_359)




































胱前立腺移行部まで切開して en bloc に摘除し（Fig.
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Fig. 1. Prostatic anterior fat pad (PAFP) mobiliza-
tion. A : Before removing PAFP. White
line : the area of removed PAFP. B : After
removing PAFP.
Table 1. Baseline characteristics of patients with absence or presence of lymph nodes in
PAFP
Overall LN absent in PAFP LN present in PAFP P-value
Number of patients (％) 215 (100) 195 (90.7) 20 (9.3) ―
Age, years : median 69 69 69.5 0.769
PSA, ng/ml : median 7.2 7.2 8.1 0.399
BMI, kg/m2 : median 23.75 23.77 23.32 0.468
Surgery 0.593
LRP 41 (19.1) 35 (17.9) 6 (30.0)
RARP 174 (80.9) 160 (82.1) 14 (70.0)
Biopsy GS (％) 0.491
6-7 113 (52.6) 104 (53.3) 9 (45.0)
8-10 102 (47.4) 91 (46.7) 11 (55.0)
Clinical stage (％) 0.502
T1c 37 (17.2) 32 (16.4) 5 (25.0)
T2 172 (80.0) 158 (81.0) 14 (70.0)
T3a 6 (2.8) 5 (2.6) 1 (5.0)
D’Amico risk (％) 0.84
Low 33 (15.3) 29 (14.9) 4 (20.0)
Intermediate 64 (29.8) 60 (30.8) 4 (20.0)
High 118 (54.9) 106 (54.3) 12 (60.0)
PAFP, Prostate anterior fat pad ; LN, Lymph node ; BMI, Body mass index ; PSA, Prostate-specific
antigen ; GS, Gleason score.
LRP, Laparoscopic radical prostatectomy.












2群間の比較には Fisher’s exact test，Mann-Whitney
U test を用い，p 値 0.05 未満を統計学的有意差あり
とした．
結 果
患者背景を Table 1 に示す．215例全体の年齢の中






パ節の個数の中央値は 1個（ 1∼ 4個）であった．前
立腺前脂肪組織内にリンパ節を認めた20例中 2 例
（10.0％，全体の0.9％）にリンパ節転移を認め，前立
泌尿紀要 64巻 9号 2018年360
Table 2. Pathological findings of patients with absence or presence of lymph nodes in
PAFP
Overall LN absent in PAFP LN present in PAFP P-value
Number of patients (％) 215 (100) 195 (90.7) 20 (9.3) ―
RP GS (％) 0.999
6-7 126 (58.6) 114 (58.5) 12 (60.0)
8-10 89 (41.4) 81 (41.5) 8 (40.0)
pT stage (％) 0.251
pT2 144 (67.0) 133 (68.2) 11 (55.0)
pT3a 40 (20.5) 34 (17.4) 6 (30.0)
pT3b 31 (14.4) 28 (14.4) 3 (15.0)
pN stage (％) 0.235
pN− 205 (95.3) 187 (95.9) 18 (90.0)
pN＋ 10 (4.7) 8 (4.1) 2 (10.0)
Margin (％) 0.777
RM0 167 (77.7) 152 (77.9) 15 (75.0)
RM1 48 (22.3) 43 (22.1) 5 (25.0)
PAFP, Prostate anterior fat pad ; LN, Lymph node ; RP, radical prostatectomy.





Fig. 2. Histopathological examination demonst-
rated lymph nodes in prostate anterior fat
pad with metastatic involvement. Hemato-












す．症例 1は58歳，PSA は 21.38 ng/ml，生検 Gleason
score は 3＋4，臨床病期は T2cN0M0 で，摘出標本の
Gleason score は 3＋4，病理学的病期は T3aN1，切除
断端は陰性で，現在まで再発を認めていない．症例 2
は73歳，PSA は 4.53 ng/ml，生検Gleason score は 3＋
5 ，臨床病期は T2aN0M0 で，摘出標本の Gleason
score は 3＋5，病理学的病期は T3bN1，切除断端は陽






り，アジア人で13人に 1人，白人で 8人に 1人，黒人
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